These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 3910302)
1. Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose. O'Carroll R; Shapiro C; Bancroft J Clin Endocrinol (Oxf); 1985 Nov; 23(5):527-38. PubMed ID: 3910302 [TBL] [Abstract][Full Text] [Related]
2. Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men. Jockenhövel F; Minnemann T; Schubert M; Freude S; Hübler D; Schumann C; Christoph A; Ernst M Eur J Endocrinol; 2009 May; 160(5):815-9. PubMed ID: 19225035 [TBL] [Abstract][Full Text] [Related]
3. Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, crossover study of a synergic role for both testosterone and sildenafil on penile erections. Rochira V; Balestrieri A; Madeo B; Granata AR; Carani C J Androl; 2006; 27(2):165-75. PubMed ID: 16278367 [TBL] [Abstract][Full Text] [Related]
4. Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study. Skakkebaek NE; Bancroft J; Davidson DW; Warner P Clin Endocrinol (Oxf); 1981 Jan; 14(1):49-61. PubMed ID: 7014044 [TBL] [Abstract][Full Text] [Related]
5. 7Alpha-methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men. Anderson RA; Martin CW; Kung AW; Everington D; Pun TC; Tan KC; Bancroft J; Sundaram K; Moo-Young AJ; Baird DT J Clin Endocrinol Metab; 1999 Oct; 84(10):3556-62. PubMed ID: 10522995 [TBL] [Abstract][Full Text] [Related]
6. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886 [TBL] [Abstract][Full Text] [Related]
7. Testosterone replacement therapy and sleep-related erections in hypogonadal men. Cunningham GR; Hirshkowitz M; Korenman SG; Karacan I J Clin Endocrinol Metab; 1990 Mar; 70(3):792-7. PubMed ID: 2307732 [TBL] [Abstract][Full Text] [Related]
8. A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. Burris AS; Banks SM; Carter CS; Davidson JM; Sherins RJ J Androl; 1992; 13(4):297-304. PubMed ID: 1399830 [TBL] [Abstract][Full Text] [Related]
9. The effects of testosterone replacement on nocturnal penile tumescence and rigidity and erectile response to visual erotic stimuli in hypogonadal men. Carani C; Granata AR; Bancroft J; Marrama P Psychoneuroendocrinology; 1995; 20(7):743-53. PubMed ID: 8848520 [TBL] [Abstract][Full Text] [Related]
10. Effects of androgen on sexual behavior in hypogonadal men. Davidson JM; Camargo CA; Smith ER J Clin Endocrinol Metab; 1979 Jun; 48(6):955-8. PubMed ID: 447801 [TBL] [Abstract][Full Text] [Related]
11. Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study. Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S BJU Int; 2016 Nov; 118(5):804-813. PubMed ID: 27124889 [TBL] [Abstract][Full Text] [Related]
12. Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients. Luisi M; Franchi F J Endocrinol Invest; 1980; 3(3):305-8. PubMed ID: 7000879 [TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study. Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964 [TBL] [Abstract][Full Text] [Related]
14. Hypogonadotropic hypogonadal men respond less well to androgen substitution treatment than hypergonadotropic hypogonadal men. Gooren L Arch Sex Behav; 1988 Jun; 17(3):265-70. PubMed ID: 3044297 [TBL] [Abstract][Full Text] [Related]
15. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Wang C; Swerdloff RS; Iranmanesh A; Dobs A; Snyder PJ; Cunningham G; Matsumoto AM; Weber T; Berman N; J Clin Endocrinol Metab; 2000 Aug; 85(8):2839-53. PubMed ID: 10946892 [TBL] [Abstract][Full Text] [Related]
16. The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men. Kwan M; Greenleaf WJ; Mann J; Crapo L; Davidson JM J Clin Endocrinol Metab; 1983 Sep; 57(3):557-62. PubMed ID: 6874890 [TBL] [Abstract][Full Text] [Related]
17. Testosterone and sleep-related erections: an overview*. Montorsi F; Oettel M J Sex Med; 2005 Nov; 2(6):771-84. PubMed ID: 16422802 [TBL] [Abstract][Full Text] [Related]
18. Testosterone undecanoate: a new orally active androgen. Hirschhäuser C; Hopkinson CR; Sturm G; Coert A Acta Endocrinol (Copenh); 1975 Sep; 80(1):179-87. PubMed ID: 1098350 [TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men. Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ J Androl; 1998; 19(6):761-8. PubMed ID: 9876028 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome. Aversa A; Bruzziches R; Francomano D; Spera G; Lenzi A J Endocrinol Invest; 2010 Dec; 33(11):776-83. PubMed ID: 20220293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]